Condition: Postoperative Analgesia After Unilateral Hip Arthroplasty · Sponsor: Beijing Tide Pharmaceutical Co., Ltd
This is a phase IIa, multicenter ,randomized, double-blind, Double-Dummy, Active- and placebo-controlled study designed to evaluate the efficacy, safety and kinetic characteristics of TRD205 tablets for postoperative analgesia after unilateral hip arthroplasty
This description comes directly from the study's public registry record.
xiaohong zhang Beijing Tide Pharmaceutical Co., Ltd · 86-10-6788-0648-5064 · zhangxh3@tidepharm.com
Always discuss trial participation with your own doctor first.
| The Third Affiliated Hospital of Southern Medical University | Guangzhou, Guangdong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07543796